Abstract
We present an unusual case of takotsubo cardiomyopathy (TTC) following administration of the second dose of the DNA ChadOX1 nCOV-19 (AZD122) vaccination. This woman in her early 50s presented to the emergency department 8 days following her vaccine with central chest pain. Initial investigations revealed a raised troponin and evolving T wave inversion on ECG. Acute coronary syndrome management was commenced. Further investigations revealed non-obstructive coronary arteries on coronary angiography and imaging revealed hypokinesia of the anterior and anterior-septal walls in the apex and midcavity level, myocardial oedema and no infarction, all in keeping with TTC. Given the large-scale roll out of vaccinations during the COVID-19 pandemic better understanding of potential adverse events is essential. This is the first case report of TTC following a second dose of the DNA ChadOX1 nCOV-19 (AZD122) vaccination.
Original language | English |
---|---|
Article number | e247291 |
Number of pages | 4 |
Journal | BMJ Case Reports |
Volume | 15 |
Issue number | 1 |
Early online date | 18 Jan 2022 |
DOIs | |
Publication status | Published - 18 Jan 2022 |
Bibliographical note
Acknowledgements Janaki Srinivasan for preparing the echocardiography images used in this report.Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Keywords
- Cardiovascular medicine
- COVID-19
- Healthcare improvement and patient safety